Epistaxis Market Projected to Reach USD 246.86 Million by 2029, Driven by Rising Hypertension Cases and Technological Advancements The epistaxis (nosebleed) market size, valued at approximately USD 170.83 million in 2022, is anticipated to grow at a compound annual growth rate (CAGR) of 5.4%, reaching nearly USD 246.86 million by 2029. This growth is primarily attributed to the...